Teva Pharmaceutical Industries Limited (FRA:TEV)

Market Cap	24.09B
Revenue (ttm)	14.30B
Net Income (ttm)	607.69M
Shares Out	n/a
EPS (ttm)	0.53
PE Ratio	39.65
Forward PE	9.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,005
Average Volume	2,935
Open	20.60
Previous Close	20.40
Day's Range	20.50 - 21.10
52-Week Range	11.15 - 21.90
Beta	n/a
RSI	71.93
Earnings Date	Nov 5, 2025

About FRA:TEV

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TEV

Financial Performance

In 2024, FRA:TEV's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD